VARIATION BIOTECHNOLOGIES (US), INC.
Profile
Company Names
VARIATION BIOTECHNOLOGIES (US), INC.
Addresses
222 3RD STREET, SUITE 2241, CAMBRIDGE, MA 02141
222 3RD STREET, CAMBRIDGE, MA 02142
245 FIRST STREET, SUITE 1100, CAMBRIDGE, MA 02142
Phone Numbers
(617) 830-3031
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2006
State Incorporated:
DELAWARE
Total Amount Raised:
$17,057,993.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2014-03-10
$1,500,000.00
$1,500,000.00
$0.00
Debt
9
2013-09-30
$1,375,000.00
$1,375,000.00
$0.00
Debt
8
2013-08-26
$250,000.00
$250,000.00
$0.00
Debt
7
2013-06-10
$750,000.00
$750,000.00
$0.00
Debt
6
2013-02-22
$751,061.00
$751,061.00
$0.00
Debt
5
2012-10-24
$1,200,000.00
$1,200,000.00
$0.00
Debt
4
2012-06-20
$1,200,000.00
$1,200,000.00
$0.00
Debt
3
2011-12-14
$2,200,000.00
$2,200,000.00
$0.00
Debt
2
2011-06-03
$3,500,000.00
$3,500,000.00
$0.00
Debt
1
2010-11-17
$4,331,932.00
$4,331,932.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFF
BAXTER
EXECUTIVE OFFICER, DIRECTOR
KEVIN
FORREST
DIRECTOR
STEVE
GILLIS
DIRECTOR
XORI CORP
| ONCOFACTOR CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| LYCERA CORP
| VBI VACCINES INC.
| ONCORESPONSE INC
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| APOGEN BIOTECHNOLOGIES, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| MAGNOLIA NEUROSCIENCES CORP
| VBI VACCINES INC/BC
| ALLY THERAPEUTICS, INC.
| SKYLARK BIO, INC.
| BASKING BIOSCIENCES, INC.
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
JEFFREY
LEIDEN
DIRECTOR
EGIDIO
NASCIMENTO
EXECUTIVE OFFICER
SCOTT
ROCKLAGE
DIRECTOR
RENNOVIA INC
| PULMATRIX INC
| 5AM CO-INVESTORS III, L.P.
| ACHAOGEN INC
| RELYPSA INC
| WAVERX INC
| SEMPRUS BIOSCIENCES CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| KINESTRAL TECHNOLOGIES, INC.
| NOVIRA THERAPEUTICS, INC.
| 5AM CO-INVESTORS IV, L.P.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| EXPANSION THERAPEUTICS, INC.
| ALBAMUNITY, INC.
MICHAEL
STEINMETZ
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
